Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine vs Sertraline in Type 2 Diabetes and Depression
NCT03978286Phase 4Completed
- Sponsor
- Universidad Juárez Autónoma de Tabasco
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of vortioxetine in major depressive disorder (MDD), sponsored by Universidad Juárez Autónoma de Tabasco. Started Jun 2016; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03978286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03978286.